Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Free Cash Flow (2021 - 2025)

Lucid Diagnostics (LUCD) has disclosed Free Cash Flow for 5 consecutive years, with -$10.9 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Free Cash Flow fell 7.47% year-over-year to -$10.9 million, compared with a TTM value of -$44.2 million through Sep 2025, up 0.62%, and an annual FY2024 reading of -$44.4 million, down 34.5% over the prior year.
  • Free Cash Flow was -$10.9 million for Q3 2025 at Lucid Diagnostics, down from -$10.5 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$2.2 million in Q3 2021 and bottomed at -$15.4 million in Q2 2022.
  • Average Free Cash Flow over 5 years is -$8.5 million, with a median of -$10.1 million recorded in 2024.
  • Peak annual rise in Free Cash Flow hit 58.31% in 2022, while the deepest fall reached 569.15% in 2022.
  • Year by year, Free Cash Flow stood at -$10.7 million in 2021, then soared by 58.31% to -$4.5 million in 2022, then plummeted by 127.62% to -$10.2 million in 2023, then increased by 0.24% to -$10.1 million in 2024, then dropped by 7.95% to -$10.9 million in 2025.
  • Business Quant data shows Free Cash Flow for LUCD at -$10.9 million in Q3 2025, -$10.5 million in Q2 2025, and -$12.6 million in Q1 2025.